260 related articles for article (PubMed ID: 23524096)
1. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage.
Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X
Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096
[TBL] [Abstract][Full Text] [Related]
2. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
4. Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells.
Cai W; Zhang B; Duan D; Wu J; Fang J
Toxicol Appl Pharmacol; 2012 Aug; 262(3):341-8. PubMed ID: 22634334
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.
Wang Y; Lu H; Wang D; Li S; Sun K; Wan X; Taylor EW; Zhang J
Toxicol Appl Pharmacol; 2012 Dec; 265(3):342-50. PubMed ID: 22982619
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
10. Curcumin sensitizes lung adenocarcinoma cells to apoptosis via intracellular redox status mediated pathway.
Kaushik G; Kaushik T; Yadav SK; Sharma SK; Ranawat P; Khanduja KL; Pathak CM
Indian J Exp Biol; 2012 Dec; 50(12):853-61. PubMed ID: 23986968
[TBL] [Abstract][Full Text] [Related]
11. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thioredoxin reductase by curcumin analogs.
Liu Z; Du ZY; Huang ZS; Lee KS; Gu LQ
Biosci Biotechnol Biochem; 2008 Aug; 72(8):2214-8. PubMed ID: 18685195
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
16. MMPT as a reactive oxygen species generator induces apoptosis via the depletion of intracellular GSH contents in A549 cells.
Zhao YF; Zhang C; Suo YR
Eur J Pharmacol; 2012 Aug; 688(1-3):6-13. PubMed ID: 22609960
[TBL] [Abstract][Full Text] [Related]
17. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
Zhang J; Yao J; Peng S; Li X; Fang J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
[TBL] [Abstract][Full Text] [Related]
18. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
Zhang J; Wang X; Lu H
Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
[TBL] [Abstract][Full Text] [Related]
19. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
